Cardinal Health (CAH)

NYSE Health Care Health Care Distributors S&P 500
$271.72
+3.90 (+1.46%)
Close of Nov 06, 2026 · end-of-day data
Source: Cardinal Health's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 09, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue$129.98B$136.81B$145.53B$152.92B$162.47B$181.33B$204.98B$226.83B$222.58B$254.25B
Cost of revenue$123.43B$129.63B$138.70B$146.05B$155.69B$174.84B$198.10B$219.41B$214.41B$244.47B
Gross profit$6.54B$7.18B$6.83B$6.87B$6.78B$6.48B$6.87B$7.41B$8.17B$9.77B
Selling, general & admin$3.77B$4.60B$4.48B$4.57B$4.53B$4.51B$4.80B$5.00B$5.38B$6.13B
Operating income$2.12B$126.00M$2.06B-$4.10B$472.00M-$607.00M$752.00M$1.24B$2.27B$2.61B
Interest expense$201.00M$329.00M$294.00M$238.00M$180.00M$147.00M$84.00M$51.00M$215.00M$348.00M
Pre-tax income$1.92B-$228.00M$1.75B-$3.77B$323.00M-$784.00M$663.00M$1.20B$2.10B$2.17B
Income tax$630.00M-$487.00M$386.00M-$79.00M-$289.00M$153.00M$332.00M$348.00M$532.00M$469.00M
Net income$1.29B$256.00M$1.36B-$3.70B$611.00M-$938.00M$330.00M$852.00M$1.56B$1.71B
EBITDA$2.84B$1.16B$3.06B-$3.19B$1.25B$85.00M$1.44B$1.95B$3.06B$3.57B
EPS (basic)$4.06$0.82$4.55$-12.61$2.09$-3.37$1.27$3.48$6.48$7.27
EPS (diluted)$4.03$0.81$4.53$-12.61$2.08$-3.37$1.26$3.45$6.45$7.23
Diluted shares320.00M315.00M301.00M293.00M294.00M279.00M262.00M247.00M242.00M237.00M
Gross margin5.0%5.2%4.7%4.5%4.2%3.6%3.4%3.3%3.7%3.8%
Operating margin1.6%0.1%1.4%-2.7%0.3%-0.3%0.4%0.5%1.0%1.0%
Net margin1.0%0.2%0.9%-2.4%0.4%-0.5%0.2%0.4%0.7%0.7%

Balance sheet

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash & equivalents$6.88B$1.76B$2.53B$2.77B$3.41B$4.72B$4.08B$5.13B$3.87B$4.86B
Short-term investments———————$200.00M——
Receivables$8.05B$7.80B$8.45B$8.26B$9.10B$10.56B$11.11B$12.08B$13.24B$13.81B
Inventory$11.30B$12.31B$12.82B$13.20B$14.59B$15.64B$16.12B$14.96B$16.83B$17.30B
Total current assets$28.34B$24.55B$25.75B$25.94B$31.05B$32.94B$33.74B$34.88B$36.37B$38.75B
Goodwill$7.22B$8.32B$8.38B$8.36B$7.99B$5.86B$4.61B$4.72B$9.69B$11.44B
Total assets$40.11B$39.95B$40.96B$40.77B$44.45B$43.88B$43.35B$45.12B$53.12B$57.30B
Total current liabilities$21.22B$22.89B$24.11B$23.61B$27.62B$30.55B$33.74B$35.64B$38.90B$43.90B
Short-term debt$1.33B$1.00B$452.00M$10.00M$871.00M$580.00M$792.00M$434.00M$550.00M$1.88B
Long-term debt$9.07B$8.01B$7.58B$6.76B$5.37B$4.74B$3.91B$4.66B$7.98B$7.00B
Total debt$10.39B$9.01B$8.03B$6.78B$6.24B$5.32B$4.70B$5.09B$8.53B$8.89B
Total liabilities$33.30B$33.89B$34.63B$38.98B$42.66B$44.59B$46.31B$48.33B$55.90B$60.18B
Shareholders' equity$6.81B$6.06B$6.33B$1.79B$1.79B-$709.00M-$2.96B-$3.21B-$2.78B-$2.88B

Cash flow

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow$1.18B$2.77B$2.72B$1.96B$2.43B$3.17B$2.84B$3.76B$2.40B$5.17B
Capital expenditures$387.00M$384.00M$328.00M$375.00M$400.00M$387.00M$481.00M$511.00M$547.00M$649.00M
Free cash flow$797.00M$2.38B$2.39B$1.58B$2.03B$2.79B$2.36B$3.25B$1.85B$4.53B
Investing cash flow-$405.00M-$5.61B$338.00M$493.00M-$378.00M$567.00M-$454.00M-$1.85B-$5.59B-$2.58B
Financing cash flow$3.75B-$2.28B-$2.29B-$2.20B-$1.32B-$2.46B-$3.05B-$847.00M$1.94B-$1.60B
Dividends paid$577.00M$581.00M$577.00M$569.00M$573.00M$559.00M$525.00M$499.00M$494.00M$491.00M
Share buybacks$600.00M$550.00M$600.00M$350.00M$200.00M$1.00B$2.00B$750.00M$765.00M$1.36B
Stock-based compensation$96.00M$85.00M$82.00M$90.00M$89.00M$81.00M$96.00M$121.00M$244.00M$367.00M
Depreciation & amortization$717.00M$1.03B$1.00B$913.00M$783.00M$692.00M$692.00M$710.00M$790.00M$956.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.